Contrast Enhanced Ultrasound Market to Surpass USD 2.1 Billion by 2030 with 6.0% CAGR Growth
Contrast Enhanced Ultrasound (CEUS) is an advanced medical imaging technique that uses microbubble contrast agents to improve the clarity and accuracy of ultrasound imaging. Unlike traditional ultrasound, CEUS provides enhanced visibility of blood vessels, tissues, and organs, making it an essential tool for diagnosing a variety of medical conditions. Its ability to offer real-time, non-invasive imaging has propelled its popularity in healthcare. The Contrast Enhanced Ultrasound Market was valued at USD 1.4 billion in 2023 and is projected to surpass USD 2.1 billion by 2030, growing at a CAGR of 6.0% from 2024 to 2030. Market Overview The CEUS market has witnessed significant growth due to its expanding applications in diagnostics and treatment monitoring. As the demand for non-invasive, accurate, and cost-effective imaging solutions increases, CEUS has become a preferred choice in various medical fields, including cardiovascular, liver, and oncology imaging. The projected growth o